Millhouse S, Krebs F C, Yao J, McAllister J J, Conner J, Ross H, Wigdahl B
The Pennsylvania State University, College of Medicine, Department of Microbiology and Immunology, Hershey 17033, USA.
J Neurovirol. 1998 Jun;4(3):312-23. doi: 10.3109/13550289809114532.
The HIV-1 LTR promoter proximal G/C box array has been demonstrated to function by interacting with the Sp1 transcription factor family whose members can act as either activators or repressors of transcription. In this regard, we have examined the interaction of the HIV-1 Sp binding sites with nuclear factors that are present in cell types that support HIV-1 replication, including those of lymphocytic, monocytic, and astrocytic origin. As determined by electrophoretic mobility shift (EMS) competition analyses using oligonucleotides containing the sequences of each of the Sp1 sites of HIV-1 strain LAI, the NF-kappaB-proximal Sp site (site III) displayed the highest binding activity compared to sites I and II with regard to Sp1 and related factors present in lymphocytic (Jurkat) and astrocytic (U-373 MG) nuclear extracts. Sp1 and two Sp3 isoforms were detected as the primary cellular constituents of DNA-protein complexes formed with the NF-kappaB-proximal site. Only modest differences in Sp1:Sp3 binding ratios were observed when this site was reacted with either astrocytic or lymphocytic nuclear extract. However, when nuclear extracts derived from two monocytic cell types that differ in the degree of differentiation were reacted with the HIV-1 LAI Sp site III, a large difference in Sp1 and Sp3 binding was observed. To determine if naturally occurring and replication-competent strains of HIV-1 contain base pair alterations within the Sp elements that affect the ability of the site to interact with Sp1 and related factors, a series of Sp site III variants were constructed and examined by EMS analyses. One of these sites, obtained from the published sequence of the YU-2 strain (a brain-derived macrophage tropic strain of HIV-1), displayed almost no Sp1 or Sp3 binding activity as a result of a single base pair alteration in Sp site III. This base-pair alteration, when placed in the context of an HIV-1 LAI LTR-luciferase construct, resulted in a 40-50% reduction in LTR activity in transiently transfected Jurkat and U-373 MG cells. Overall, these results suggest that specific G/C box sequence alterations present in the brain-derived HIV-1 variant YU-2, or possibly other brain-derived variants, may exhibit altered replication properties as a result of the low affinity of the NF-kappaB-proximal G/C box for members of the Sp transcription factor family.
HIV-1长末端重复序列(LTR)启动子近端的G/C盒阵列已被证明可通过与Sp1转录因子家族相互作用来发挥功能,该家族成员可作为转录激活剂或抑制剂。在这方面,我们研究了HIV-1的Sp结合位点与支持HIV-1复制的细胞类型(包括淋巴细胞、单核细胞和星形细胞来源的细胞)中存在的核因子之间的相互作用。通过使用含有HIV-1 LAI株每个Sp1位点序列的寡核苷酸进行电泳迁移率变动(EMS)竞争分析确定,就淋巴细胞(Jurkat)和星形细胞(U-373 MG)核提取物中存在的Sp1及相关因子而言,NF-κB近端的Sp位点(位点III)与位点I和II相比显示出最高的结合活性。检测到Sp1和两种Sp3异构体是与NF-κB近端位点形成的DNA-蛋白质复合物的主要细胞成分。当该位点与星形细胞或淋巴细胞核提取物反应时,仅观察到Sp1:Sp3结合比例的适度差异。然而,当来自两种分化程度不同的单核细胞类型的核提取物与HIV-1 LAI Sp位点III反应时,观察到Sp1和Sp3结合存在很大差异。为了确定天然存在且具有复制能力的HIV-1毒株在Sp元件内是否含有影响该位点与Sp1及相关因子相互作用能力的碱基对改变,构建了一系列Sp位点III变体并通过EMS分析进行检测。其中一个位点取自YU-2株(一种源自脑的HIV-1巨噬细胞嗜性毒株)的已发表序列,由于Sp位点III中的单个碱基对改变,该位点几乎没有Sp1或Sp3结合活性。当将这种碱基对改变置于HIV-1 LAI LTR-荧光素酶构建体的背景下时,在瞬时转染的Jurkat和U-373 MG细胞中,LTR活性降低了40-50%。总体而言,这些结果表明,源自脑的HIV-1变体YU-2或可能的其他源自脑的变体中存在的特定G/C盒序列改变,可能由于NF-κB近端G/C盒对Sp转录因子家族成员的低亲和力而表现出改变的复制特性。